FORTREA HOLDINGS DL-,001 Aktie

Fortrea has introduced Fortrea Intelligent Technology (FIT), a suite of people-centered, AI-powered solutions to automate workflows, optimize monitoring, and accelerate clinical trials. FIT builds on the Xcellerate platform and offers applications for biopharma, biotechnology, and medical device companies in full-service, functional-service, and SaaS models. The suite is organized into three pillars — lifecycle, foresight, and support — and provides role-based insights in near real time to improve predictability, quality, and productivity. » Plus sur finanzen.net

Fortrea introduced Fortrea Intelligent Technology (FIT), an AI-powered suite that includes extensions to the Xcellerate platform and new Lifecycle, Foresight and Companion modules. The tools automate workflows, integrate study data for role-specific insights and use AI/ML for pattern analysis and predictive signal generation; selected components will be offered as SaaS. The announcement comes as the stock trades below $10 and analysts project a return to profitability. » Plus sur de.investing.com

Fortrea has reorganized its leadership team: Oren Cohen will focus exclusively on the role of chief medical officer with responsibility for medical strategy, scientific leadership, ethics and governance. Scott Dove will take over as president of Clinical Pharmacology Services, leading early clinical development solutions across Fortrea’s global network. Both are members of the executive committee and are expected to strengthen Fortrea’s client service and clinical pharmacology expertise. » Plus sur finanzen.net